Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 15;3(2):330-334.
doi: 10.1016/j.jaccao.2021.02.005. eCollection 2021 Jun.

Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy: Endomyocardial Biopsy Provides Pathological Insights to Dual Diseases

Affiliations
Review

Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy: Endomyocardial Biopsy Provides Pathological Insights to Dual Diseases

Michael Serzan et al. JACC CardioOncol. .
No abstract available

Keywords: ICI, immune checkpoint inhibitor; TTE, transthoracic echocardiogram; Takotsubo cardiomyopathy; histopathology; imaging; immune checkpoint inhibitors; immunotherapy; irAE, immune-related adverse event.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Cardiac Magnetic Resonance Imaging T2-weighted dark blood images (asterisks) show increased signal intensity in the left ventricular (LV) apical segments indicating presence of myocardial edema. LA = left atrium; RA = right atrium; RV = right ventricle.
Figure 2
Figure 2
Endomyocardial Biopsy and Chest Computed Tomography (A) Endomyocardial biopsy shows focal fibrosis without malignancy or myocarditis. Immunostaining for CD68 shows very rare macrophages (yellow arrows). (B) Chest computed tomography shows moderate consolidation in the bilateral posterior lower lobes with adjacent ground glass opacities (yellow asterisks).

References

    1. Ramos-Casals M., Brahmer J.R., Callahan M.K. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6:1–21. - PMC - PubMed
    1. Palaskas N., Lopez-Mattei J., Durand J.B. Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc. 2020;9 - PMC - PubMed
    1. Wilson H.M., Cheyne L., Brown P.A. Characterization of the myocardial inflammatory response in acute stress-induced (Takotsubo) cardiomyopathy. J Am Coll Cardiol Basic Trans Science. 2018;3:766–778. - PMC - PubMed
    1. Caforio A.L., Pankuweit S., Arbustini E. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–2648d. - PubMed
    1. Desai A., Noor A., Joshi S. Takotsubo cardiomyopathy in cancer patients. Cardiooncology. 2019;5:7. - PMC - PubMed

LinkOut - more resources